{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:18:47Z","timestamp":1781759927580,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["JP15K18945"],"award-info":[{"award-number":["JP15K18945"]}]},{"name":"Fukuoka Foundation for Sound Health Cancer Research Fund"},{"DOI":"10.13039\/501100005738","name":"Central Research Institute of Fukuoka University","doi-asserted-by":"publisher","award":["181045"],"award-info":[{"award-number":["181045"]}],"id":[{"id":"10.13039\/501100005738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jphs.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T19:03:59Z","timestamp":1549825439000},"page":"231-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination model"],"prefix":"10.1016","volume":"139","author":[{"given":"Mai","family":"Hazekawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nishinakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Kawakubo-Yasukochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6669","key":"10.1016\/j.jphs.2019.01.009_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"issue":"6836","key":"10.1016\/j.jphs.2019.01.009_bib2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.jphs.2019.01.009_bib3","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1101\/gad.13.24.3191","article-title":"Targeted mRNA degradation by double-stranded RNA in\u00a0vitro","volume":"13","author":"Tuschl","year":"1999","journal-title":"Gene Dev"},{"issue":"11","key":"10.1016\/j.jphs.2019.01.009_bib4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3109\/03639045.2013.828220","article-title":"The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model","volume":"40","author":"Hazekawa","year":"2014","journal-title":"Drug Dev Ind Pharm"},{"issue":"7","key":"10.1016\/j.jphs.2019.01.009_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1248\/cpb.c17-00025","article-title":"Effect of self-healing encapsulation on the initial burst release from PLGA microspheres containing a long-acting prostacyclin agonist, ONO-1301","volume":"65","author":"Hazekawa","year":"2017","journal-title":"Chem Pharm Bull"},{"issue":"2","key":"10.1016\/j.jphs.2019.01.009_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1357-2725(02)00095-X","article-title":"Glypicans","volume":"35","author":"Fransson","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"10.1016\/j.jphs.2019.01.009_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/pgp.0b013e31802d692c","article-title":"Glypican-3 expression in primary and recurrent ovarian carcinomas","volume":"26","author":"Stadlmann","year":"2007","journal-title":"Int J Gynecol Pathol"},{"issue":"6","key":"10.1016\/j.jphs.2019.01.009_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/modpathol.2009.40","article-title":"Glypican-3 expression in clear cell adenocarcinoma of the ovary","volume":"22","author":"Maeda","year":"2009","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.009_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0016-5085(03)00689-9","article-title":"Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma","volume":"125","author":"Capurro","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.009_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-291X(03)00908-2","article-title":"Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker","volume":"306","author":"Nakatsuka","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.jphs.2019.01.009_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12032-011-9973-1","article-title":"Expression of GPC3 protein and its significance in lung squamous cell carcinoma","volume":"29","author":"Lin","year":"2012","journal-title":"Med Oncol"},{"issue":"19","key":"10.1016\/j.jphs.2019.01.009_bib12","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1158\/1078-0432.CCR-04-0348","article-title":"Identification of glypican-3 as a novel tumor marker for melanoma","volume":"10","author":"Nakatsuka","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.jphs.2019.01.009_bib13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3892\/or.2014.3300","article-title":"GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth","volume":"32","author":"Luo","year":"2014","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.jphs.2019.01.009_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jconrel.2010.12.007","article-title":"Self-assembled siRNA\u2013PLGA conjugate micelles for gene silencing","volume":"152","author":"Lee","year":"2011","journal-title":"J\u00a0Contr Release"},{"issue":"7","key":"10.1016\/j.jphs.2019.01.009_bib15","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/j.actbio.2014.03.012","article-title":"Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapy","volume":"10","author":"Dakwer","year":"2014","journal-title":"Acta Biomater"},{"issue":"4","key":"10.1016\/j.jphs.2019.01.009_bib16","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3892\/or.2017.5882","article-title":"Atelocollagen-mediated in\u00a0vivo siRNA transfection in ovarian carcinoma is influenced by tumors site, siRNA target and administration route","volume":"38","author":"Meryet-Figui\u00e8re","year":"2017","journal-title":"Oncol Rep"},{"issue":"8","key":"10.1016\/j.jphs.2019.01.009_bib17","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3109\/0284186X.2012.726373","article-title":"Peritoneal macrophages mediated delivery of chitosan\/siRNA nanoparticle to the lesion site in a murine radiation-induced fibriosis model","volume":"52","author":"Nawroth","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jphs.2019.01.009_bib18","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2147\/IJN.S155537","article-title":"Superparamagnetic iron oxide nanoparticles modified with polyethylenimine and galactose for siRNA targeted delivery in hepatocellular carcinoma therapy","volume":"13","author":"Yang","year":"2018","journal-title":"Int J Nanomed"},{"issue":"5","key":"10.1016\/j.jphs.2019.01.009_bib19","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/hep.23848","article-title":"The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation","volume":"52","author":"Lai","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jphs.2019.01.009_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.26996","article-title":"Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy","volume":"60","author":"Gao","year":"2014","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jphs.2019.01.009_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137664","article-title":"Human monoclonal antibody targeting the heparan chains of glypican-3 inhibits HGF-mediated migration and motility of hepatocellular carcinoma cells","volume":"10","author":"Gao","year":"2015","journal-title":"PLoS One"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319300143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861319300143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T15:41:58Z","timestamp":1565192518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861319300143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1347861319300143"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2019.01.009","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glypican-3 gene silencing for ovarian cancer using siRNA-PLGA hybrid micelles in a murine peritoneal dissemination model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}